Cand.scient. Aslaug Aamodt Muggerud from Anne-Lise Børresen-Dale's group at the Department of Genetics at the Institute for Cancer Research gave her trial lecture on the subject "Clinical utility of genetic and epigenetic markers in the management of cancer. Current status" on Friday November 13th at 10.30.
She defends her PhD thesis - entitled "Genetic and epigenetic alterations in breast tumour progression: The transition from in situ to invasive cancer" on Friday November 13th at 13.15.
Venue for both events: Auditorium U1, The Norwegian Radium Hospital at Montebello.
From major journals, first or last author from the Institute for Cancer Research
PoDCall: positive droplet calling and normalisation of droplet digital PCR DNA methylation data
Bioinformatics (in press)
Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru
Cancers (Basel), 14 (22)
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053